Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder
Psilocybin Research Treatment for People with Significant Body Image Concerns
Sponsor:COMPASS Pathways
Enrolling:Male and Female Patients
Study Length:3 Months
Clinic Visits:8
Age Range:Between 18 and 55 years old
IRB Number:7950
U.S. Government ID:NCT04656301
Contact: Gloria Gomez: (646) 450-4572 / gloria.gomez@nyspi.columbia.edu
Additional Study Information:

We are currently enrolling individuals with significant and distressing body image concerns to participate in a research study that will assess whether a single dose of psilocybin may be a safe and effective treatment to improve appearancerelated worries. Individuals may be eligible if they are not currently on psychiatric medications and have tried an anti-depressant (SSRI, SNRI, or Clomipramine) in the past. For eligible participants, the research study will involve 1 visit that is around 8 hours during which they will receive psilocybin with the support of a therapist. Participants will then return for follow-up visits over the course of 12 weeks. The study will also assess the effect of the treatment on brain activity using a scan called magnetic resonance imaging (MRI). Participants will receive compensation for completing the study

Do You Qualify?
Are you between the ages of 18-55?YesNo
Do you think about your appearance problems a lot and wish you could think less about them?YesNo
Have these thoughts about your appearance problems interfered with your relationships, work, or daily life?YesNo
Are you currently taking psychiatric medications?YesNo
Have you tried at least one medication in the past for this problem?YesNo
Submit
Cancel
Investigator
Franklin Schneier, MD
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Gloria Gomez
Email: gloria.gomez@nyspi.columbia.edu
Phone: (646) 450-4572